Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05061238
Other study ID # 2021-0620
Secondary ID NCI-2021-09935
Status Recruiting
Phase N/A
First received
Last updated
Start date October 4, 2021
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source M.D. Anderson Cancer Center
Contact David McCall
Phone 713) 792-6604
Email dmccall1@mdanderson.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-site interventional open label pilot study of a non-significant risk medical device on patients with defined peripheral neuropathy secondary to chemotherapy (N=10). Patients who have received chemotherapy and have evidence of neuropathy will be seen at MD Anderson. Their severity of neuropathy will be documented and assessed by physical therapy, occupational therapy and based on self-reported activities of daily living (ADL) impairment.


Description:

Primary Objective: To assess the effect of a vibrating device applied to selected muscles on the step Secondary Objectives: - To summarize the adverse events of different levels from using the vibrator device in oncologic AYA patients visiting the outpatient clinic. - To summarize the irritation, pain, and sensation of the application of vibration by the AYA patients, as determined by the survey during the application


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years to 39 Years
Eligibility Inclusion Criteria: - Subjects between the ages of 6 and 39 years. - Study subjects, or their parent/legal guardian for subjects <18 years, must be able to understand the purpose and risks of the study and to provide signed and dated informed consent and authorization to use confidential health information in accordance with national and local subject privacy regulations. - History of any type of cancer- - Diagnosed with peripheral neuropathy-associated gait dysfunction as defined by the treating physician. - Able (in the Investigators estimation) and willing to comply with all study requirements. - Subjects must be able to walk; assistance of a walker or similar support apparatus is allowed. - Patients with ankle foot orthosis (AFOs) are allowed but will need to be removed prior to testing. Exclusion Criteria: - Participants with amputations, prosthetics, congenital malformations or any severe lower extremity deformities affecting gait before trials. - Abnormalities of the lower extremities as determined by the investigator. - Unstable participants or participants with hypotension (systolic blood pressure <90 and diastolic blood pressure < 60mmHg). - Any other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study. - Other unspecified reasons that, in the opinion of the Investigator make the subject unsuitable for enrolment - Pregnant women - Children <15 years old - Blind

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Vibrating Device
The vibrating device strapped to different parts of your leg. The device will be secured to your leg with a Velcro strap.

Locations

Country Name City State
United States M D Anderson Cancer Center Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To establish the effect of a vibrating device applied to selected muscles on the step times of adolescent or young adult (AYA). through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT04203212 - BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH
Recruiting NCT04363606 - Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability N/A
Active, not recruiting NCT05984186 - Wingate-type Exercise Test to Evaluate the Effect of High Velocity Therapy on Recovery Sensation and Blood Lactate Decline
Completed NCT02702219 - Effect of Flexibility Training Versus Static Stretching on Hamstring Muscle Length and Patterns of Lumbar Flexion N/A
Recruiting NCT06074822 - Research Biobank From Neuromuscular Biopsy Residues (in the Context of Care)
Completed NCT06070064 - Effects of Trap and Reggaeton Music on Movement Velocity, Power and Muscular Endurance in the Lower Limbs of Physically Active Women N/A
Completed NCT05586451 - Muscle Activation With Acute Bouts of Blood Flow Restricted Resistance Exercise N/A
Completed NCT01749189 - Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength N/A
Not yet recruiting NCT06164249 - Quantification of Internal Training Load N/A
Completed NCT03424551 - Vibration Induced Reflex Responses and Estimation of TVR N/A
Recruiting NCT05506228 - How Are the Muscles Affected in Cerebral Palsy? A Study of Muscle Biopsies Taken During Orthopaedic Surgery.
Recruiting NCT04277494 - The Acute Effect of Cold Spray Application on the Mechanical Properties of the Quadriceps Muscle in Athletes N/A
Completed NCT01316731 - MyoGene: Effects of Acute Exercise on (Myokine) Gene Expression in Human Skeletal Muscle N/A
Withdrawn NCT03849326 - Chronic Fatigue Etiology in Intensive Care Unit Survivors: the Role of Neuromuscular Function N/A
Completed NCT03319095 - Intravaginal Electrical Nerve Stimulation in Women With Non-contracting Pelvic Floor N/A
Completed NCT05206383 - Influence of Oral Messages on the Activity of Wrist and Finger Flexor Muscles N/A
Completed NCT03016559 - Effect of Releasing Quadratus Lumborum Muscle on Hip Joint Range of Motion in Asymptomatic Individuals N/A
Recruiting NCT05885139 - Exopulse Mollii Suit, Motor Functions & CP Children With Cerebral Palsy N/A

External Links